Abstract:Neuromyelitis optica (NMO) has been traditionally described as the association of recurrent or bilateral optic neuritis and longitudinally extensive transverse myelitis (LETM). Identification of aquaporin-4 antibody (AQP4-IgG) has deeply changed the concept of NMO. A spectrum of NMO disorders (NMOSD) has been formulated comprising conditions which include both AQP4-IgG seropositivity and one of the index events of the disease (recurrent or bilateral optic neuritis and LETM). Most NMO patients harbor asymptomat… Show more
“…1: Lesions present in up to 60% of patients [9]; 2: Lesions located periventricular zone and brainstem a (involving more frequently its central and dorsal aspects [28]). 3: Lesions localized at sites of high AQP4 expression such as in hypothalamus a [28] .…”
Section: Findings/diseasementioning
confidence: 99%
“…3: Lesions localized at sites of high AQP4 expression such as in hypothalamus a [28] . 4: Corticospinal tract lesions frequently bilateral involving the posterior limb of the internal capsule and the cerebral peduncle a [28]. 5: Lesions lining the ependymal surface of the lateral ventricles a [28].…”
Section: Findings/diseasementioning
confidence: 99%
“…4: Corticospinal tract lesions frequently bilateral involving the posterior limb of the internal capsule and the cerebral peduncle a [28]. 5: Lesions lining the ependymal surface of the lateral ventricles a [28]. 6: Acute phaselarge edematous and heterogeneous lesions in the corpus callosum; Chronic phase -reduction in their size and intensity or even its disappearance a [28].…”
Section: Findings/diseasementioning
confidence: 99%
“…5: Lesions lining the ependymal surface of the lateral ventricles a [28]. 6: Acute phaselarge edematous and heterogeneous lesions in the corpus callosum; Chronic phase -reduction in their size and intensity or even its disappearance a [28].…”
Transverse myelitis (TM) is an inflammatory condition caused by a range of possibilities which can lead to a deregulation of our motor, sensory and autonomic systems. Therefore, it creates a major impact on personal and professional life. Because it causes great social and professional disability, it is crucial that the clinicians quickly recognize this condition so that treatment can be started thereby minimizing these negative effects. Thus, the aim of this review is to provide a practical clinical approach to the most important causal diseases of TM, clinical presentation and to elaborate a diagnostic algorithm that helps classifying and simplifying the work of the clinicians when facing a TM episode.
“…1: Lesions present in up to 60% of patients [9]; 2: Lesions located periventricular zone and brainstem a (involving more frequently its central and dorsal aspects [28]). 3: Lesions localized at sites of high AQP4 expression such as in hypothalamus a [28] .…”
Section: Findings/diseasementioning
confidence: 99%
“…3: Lesions localized at sites of high AQP4 expression such as in hypothalamus a [28] . 4: Corticospinal tract lesions frequently bilateral involving the posterior limb of the internal capsule and the cerebral peduncle a [28]. 5: Lesions lining the ependymal surface of the lateral ventricles a [28].…”
Section: Findings/diseasementioning
confidence: 99%
“…4: Corticospinal tract lesions frequently bilateral involving the posterior limb of the internal capsule and the cerebral peduncle a [28]. 5: Lesions lining the ependymal surface of the lateral ventricles a [28]. 6: Acute phaselarge edematous and heterogeneous lesions in the corpus callosum; Chronic phase -reduction in their size and intensity or even its disappearance a [28].…”
Section: Findings/diseasementioning
confidence: 99%
“…5: Lesions lining the ependymal surface of the lateral ventricles a [28]. 6: Acute phaselarge edematous and heterogeneous lesions in the corpus callosum; Chronic phase -reduction in their size and intensity or even its disappearance a [28].…”
Transverse myelitis (TM) is an inflammatory condition caused by a range of possibilities which can lead to a deregulation of our motor, sensory and autonomic systems. Therefore, it creates a major impact on personal and professional life. Because it causes great social and professional disability, it is crucial that the clinicians quickly recognize this condition so that treatment can be started thereby minimizing these negative effects. Thus, the aim of this review is to provide a practical clinical approach to the most important causal diseases of TM, clinical presentation and to elaborate a diagnostic algorithm that helps classifying and simplifying the work of the clinicians when facing a TM episode.
“…Currently, the diagnosis of NMOSD is usually suspected in patients with the following phenotypes: monophasic or recurrent NMO, monophasic or recurrent longitudinally extensive transverse myelitis (LETM) that extends over three or more vertebral segments, and bilateral simultaneous or recurrent ON 6 . Although many patients have no lesions outside the optic nerve and spinal cord, several reports confirmed that NMOSD patients might also have some characteristic brain or brainstem lesions for NMO 7,8,9,10 , resulting in proposed diagnostic criteria that includes more features now considered typical for NMOSD 11 . Serum antibodies against aquaporin-4 (AQP4) are present in the majority of NMOSD patients and its discovery clearly segregated NMOSD from multiple sclerosis (MS) 12 .…”
Neuromyelitis optica spectrum disorders (NMOSD) are characterized by severe optic neuritis and/or longitudinally extensive transverse myelitis, and some brain lesions are also unique to NMOSD. Serum autoantibodies against aquaporin-4 (AQP4) are detected in most cases of NMOSD. However, some patients with NMOSD remain seronegative despite repetitive testing during attacks with highly sensitive cellbased assays. The differential diagnosis of NMOSD is not restricted to multiple sclerosis and it includes many diseases that can produce longitudinally extensive myelitis and/or optic neuritis. We review the clinical features, imaging, and laboratory findings that can be helpful on the diagnostic work-up, discuss the differences between AQP4 antibody positive and negative patients with NMOSD, including features of NMOSD with antibodies against myelin oligodendrocyte glycoprotein.Keywords: neuromyelitis optica, aquaporin-4, myelin oligodendrocyte glycoprotein, antibody, myelitis, optic neuritis, differential diagnosis.
RESUMOO espectro da neuromielite óptica (NMOSD) é caracterizado por ataques graves de neurite óptica e mielite. Anticorpos séricos contra a aquaporina-4 (AQP4) são usualmente presentes nestes pacientes. Entretanto, alguns pacientes com NMOSD são seronegativos mesmo com testes repetidos em amostras obtidas durante ataques usando métodos altamente sensíveis baseados em células. O diagnóstico diferencial não é restrito à esclerose múltipla e inclui muitas doenças que podem produzir mielite longitudinalmente extensa e/ou neurite óptica. São abordadas as características clínicas, de imagem e de laboratório que podem ser úteis no diagnóstico, as diferenças entre os pacientes positivos para o anticorpo anti-AQP4 e os negativos, incluindo as características dos pacientes com NMOSD que possuem anticorpos contra a glicoproteína associada ao oligodendrócito.Palavras-chave: neuromielite óptica, aquaporina-4, glicoproteína associada ao olidendrócito, mielite, neurite óptica, diagnóstico diferencial.
Neuromyelitis optica (NMO) is a severe inflammatory demyelinating disease with exacerbations involving recurrent or bilateral optic neuritis and longitudinally extensive transverse myelitis. Pulse steroid therapy is recommended as the initial, acute-phase treatment for NMO. If ineffective, treatment with plasma exchange (PE) should commence. However, no evidence exists to support the effectiveness of PE long after the acute phase. Immunoadsorption therapy (IA) eliminates pathogenic antibodies while sparing other plasma proteins. With IA, side effects of PE resulting from protein substitution can be avoided. However, whether IA is effective for NMO remains unclear. We describe a patient with anti-aquaporin-4-positive myelitis who responded to IA using a tryptophan polyvinyl alcohol gel column that was begun 52 days after disease onset following the acute phase. Even long after the acute phase when symptoms appear to be stable, IA may be effective and should not be excluded as a treatment choice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.